ClearBridge Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.1M | Sell |
736,279
-78,494
| -10% | -$6.51M | 0.05% | 287 |
|
2025
Q1 | $66.1M | Buy |
814,773
+243,109
| +43% | +$19.7M | 0.06% | 276 |
|
2024
Q4 | $51.5M | Buy |
571,664
+97,401
| +21% | +$8.77M | 0.04% | 316 |
|
2024
Q3 | $46.9M | Buy |
+474,263
| New | +$46.9M | 0.04% | 336 |
|
2018
Q3 | – | Sell |
-6,385
| Closed | -$608K | – | 1165 |
|
2018
Q2 | $608K | Hold |
6,385
| – | – | ﹤0.01% | 673 |
|
2018
Q1 | $560K | Hold |
6,385
| – | – | ﹤0.01% | 673 |
|
2017
Q4 | $542K | Hold |
6,385
| – | – | ﹤0.01% | 684 |
|
2017
Q3 | $553K | Hold |
6,385
| – | – | ﹤0.01% | 679 |
|
2017
Q2 | $493K | Hold |
6,385
| – | – | ﹤0.01% | 682 |
|
2017
Q1 | $443K | Buy |
6,385
+585
| +10% | +$40.6K | ﹤0.01% | 723 |
|
2016
Q4 | $343K | Buy |
5,800
+2,500
| +76% | +$148K | ﹤0.01% | 748 |
|
2016
Q3 | $219K | Buy |
+3,300
| New | +$219K | ﹤0.01% | 765 |
|